- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05844904
Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia and Development of Artificial Intelligence Modelling
Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia (BSTI-Ina) Questionnaire and Development of Artificial Intelligence Modelling BSTI-Ina: A Multicentric Study
The goal of this observational study is to learn about the skin type of Indonesians based on Baumann Skin Type Indicator Questionnaire in Indonesian language version, and to develop artificial intelligence modelling of BSTI-Ina. The main questions it aims to answer are:
- What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2006 version which was adapted from BSTI questionnaire in English language year 2006 version as a specific measurement to identify skin type?
- What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2022 version which was adapted from BSTI questionnaire in English language year 2022 version as a specific measurement to identify skin type?
- What is the comparison of the validity and reliability between BSTI-Ina questionnaire year 2006 and year 2022 to determine Indonesian adult population's skin type?
- How is the mapping of Indonesians' skin type based on BSTI-Ina?
- What is the proportion of each skin type based on BSTI-Ina in Indonesian population?
- What is the proportion of each skin type based on BSTI-Ina in Indonesian population sociodemographically?
- How can Artificial Intelligence help categorize skin type based on BSTI-Ina automatically?
Participants are males and females between 18-59 year old. Participants will be asked to fill BSTI-Ina questionnaire. Participants then will be photographed in five different positions.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Irma Bernadette, MD
- Phone Number: +62818130761
- Email: irma_bernadette@yahoo.com
Study Locations
-
-
Bali
-
Denpasar, Bali, Indonesia, 80113
- Rumah Sakit Umum Pusat Prof. Dr. I Goesti Ngoerah Gde Ngoerah
-
Contact:
- I Gusti Ayu A Praharsini, MD
- Phone Number: +628123888794
-
-
Central Java
-
Semarang, Central Java, Indonesia, 50244
- Rumah Sakit Umum Pusat Dr. Kariadi
-
Contact:
- Puguh Riyanto, MD
- Phone Number: +628113319892
-
Surakarta, Central Java, Indonesia, 57126
- Rumah Sakit Umum Daerah Dr. Moewardi
-
Contact:
- Arie Kusumawardani, MD
- Phone Number: +628122840012
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
-
Principal Investigator:
- Irma BS Sitohang, MD
-
Sub-Investigator:
- Hanny Nilasari, MD
-
Sub-Investigator:
- Sandra Widaty, MD
-
Sub-Investigator:
- Irwan Batubara, MD
-
Contact:
- Irma BS Sitohang, MD
- Phone Number: +62818130761
- Email: irma_bernadette@yahoo.com
-
-
East Java
-
Malang, East Java, Indonesia, 65112
- Rumah Sakit Umum Daerah Dr. Saiful Anwar
-
Contact:
- Shinta Murlistyarini, MD
- Phone Number: +6281325466699
-
Surabaya, East Java, Indonesia, 60286
- Rumah Sakit Umum Daerah Dr. Soetomo
-
Contact:
- Diah M Indramaya, MD
- Phone Number: +628123037841
-
-
North Sulawesi
-
Manado, North Sulawesi, Indonesia, 95262
- Rumah Sakit Umum Pusat Prof. dr. R. D. Kandou
-
Contact:
- Marlyn G Kapantow, MD
- Phone Number: +628124302030
-
-
North Sumatra
-
Medan, North Sumatra, Indonesia, 20154
- Rumah Sakit Universitas Sumatera Utara
-
Contact:
- Nelva K Jusuf, MD
- Phone Number: +62811651432
-
-
South Sulawesi
-
Makassar, South Sulawesi, Indonesia, 90245
- Rumah Sakit Umum Pusat Dr. dr. Wahidin Sudirohusodo
-
Contact:
- Asnawi Madjid, MD
- Phone Number: +6281342765752
-
-
South Sumatra
-
Palembang, South Sumatra, Indonesia, 30126
- Rumah Sakit Umum Pusat Dr. Mohammad Hoesin
-
Contact:
- Yuli Kurniawati, MD
- Phone Number: +628127150511
-
-
Special Region Of Yogyakarta
-
Yogyakarta, Special Region Of Yogyakarta, Indonesia, 55281
- Rumah Sakit Umum Pusat Dr. Sardjito
-
Contact:
- Flandiana Yogianti, MD
- Phone Number: +6282138470777
-
-
West Java
-
Bandung, West Java, Indonesia, 40161
- Rumah Sakit Umum Pusat Dr. Hasan Sadikin
-
Contact:
- Reti Hindritiani, MD
- Phone Number: +628156022505
-
-
West Sumatra
-
Padang, West Sumatra, Indonesia, 25171
- Rumah Sakit Umum Pusat Dr. M. Djamil
-
Contact:
- Satya W Yenny, MD
- Phone Number: +628126617869
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Males and females age 18-59 year old.
- Fitzpatrick's skin type III-V
- Educational degree of minimum high school
- Can speak Indonesian
- Can read
- Willing to participate and sign informed consent
Exclusion Criteria:
- Participant who doesn't fill the questionnaire completely
- Participant with skin disease involving >25% facial area
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
General
This research is an observational study.
There's no control and experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language
Time Frame: Up to 2 weeks
|
Adapting Baumann Skin Type Indicator questionnaire 2006 version to Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language by certified translators
|
Up to 2 weeks
|
Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language
Time Frame: Up to 2 weeks
|
Adapting Baumann Skin Type Indicator questionnaire 2022 version to Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language by certified translators
|
Up to 2 weeks
|
More valid and reliable version of Baumann Skin Type Indicator-Ina questionnaire (2006 or 2022 version)
Time Frame: Up to 1 month
|
Comparing between Baumann Skin Type Indicator-Ina questionnaire 2006 version and 2022 version by statistician
|
Up to 1 month
|
Mapping of Indonesian population's skin type based on Baumann Skin Type Indicator-Ina
Time Frame: Up to 2 months
|
Determine the proportion of Indonesia population's skin type based on Baumann Skin Type Indicator in 13 research centers
|
Up to 2 months
|
Capability of artificial intelligence model to categorize skin type based on Baumann Skin Type Indicator-Ina
Time Frame: Up to 1 month
|
Data such as participants' skin types and photographs will be analyzed by machine resulting AI to categorize skin type automatically by photographs.
|
Up to 1 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Irma Bernadette, MD, Faculty of medicine, University of Indonesia
- Study Director: Hanny Nilasari, MD, Faculty of medicine, University of Indonesia
- Study Director: Sandra Widaty, MD, Faculty of medicine, University of Indonesia
- Study Director: Nelva K Jusuf, MD, Faculty of Medicine, University of North Sumatra
- Study Director: Puguh Riyanto, MD, Faculty of Medicine, Diponegoro University
- Study Director: Asnawi Madjid, MD, Faculty of Medicine, Hasanuddin University
- Study Director: Marlyn G Kapantow, MD, Faculty of Medicine, Sam Ratulangi University
- Study Director: I Gusti Ayu A Praharsini, MD, Faculty of Medicine, Udayana University
- Study Director: Reti Hindritiani, MD, Faculty of Medicine, Padjadjaran University
- Study Director: Diah M Indramaya, MD, Faculty of Medicine, Airlangga University
- Study Director: Yuli Kurniawati, MD, Faculty of Medicine, Sriwijaya University
- Study Director: Satya W Yenny, MD, Faculty of Medicine, Andalas University
- Study Director: Arie Kusumawardani, MD, Faculty of Medicine, Sebelas Maret University
- Study Director: Shinta Murlistyarini, MD, Faculty of Medicine, Brawijaya University
- Study Director: Flandiana Yogianti, MD, Faculty of Medicine, Gadjah Mada University
- Study Director: Aria Kekalih, MD, Faculty of medicine, University of Indonesia
- Study Director: Prasandhya A Yusuf, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
- Study Director: Eric D Tenda, MD, Indonesia Medical Education and Research Institute, University of Indonesia
- Study Director: Vanya V Valindria, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
- Study Director: Sari Chairunnisa, MD, Paragon Technology & Innovation
- Study Director: Irwan Batubara, MD, Faculty of medicine, University of Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- MappingofBSTI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Baumann Skin Type Indicator
-
Chelsea and Westminster NHS Foundation TrustHIV in Europe (Co-Sponsor)UnknownHIV | AIDS | Indicator Diseases/Indicator ConditionsUnited Kingdom
-
Hospital Sirio-LibanesCompletedColorectal Cancer | Colonoscopy | Adenoma Detection Rate | Adenoma Colon | Colorectal Polyp | Sessile Serrated Adenoma | Quality IndicatorBrazil
-
AmgenCompletedPsoriasis-Type Psoriasis | Plaque-Type PsoriasisUnited States
-
AmgenCompletedPsoriasis | Plaque-type PsoriasisUnited States, Canada
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompletedPlaque-Type PsoriasisUnited States
-
PfizerCompletedPlaque-type PsoriasisAustralia
-
TetraLogic PharmaceuticalsCompleted
-
Galderma R&DCompletedPlaque-type PsoriasisUnited States
-
Deltanoid PharmaceuticalsCompletedPlaque-type PsoriasisUnited States